Healthcare
Insulet Corporation
PODD$142.28-3.53%
Price is delayed.
Add to watchlist
About Insulet Corporation
Insulet makes Omnipod, a small wireless pod that delivers insulin under the skin for people with diabetes who need insulin injections. The Omnipod 5 system reads blood sugar automatically through a continuous glucose monitor and adjusts insulin doses on its own. Patients control the pod using a handheld device or smartphone instead of traditional insulin pens and syringes. The company also makes pods for a cancer drug delivery system sold by Amgen.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore